Request for Covid-19 Impact Assessment of this Report
The United States HIV Diagnostics market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global HIV Diagnostics market, reaching US$ million by the year 2028. As for the Europe HIV Diagnostics landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main HIV Diagnostics players cover Abbott, Abbott Healthcare, Abbvie Inc., and Brsitol-Myers Squibb, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of HIV Diagnostics market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Consumables
Assay, Kits and Reagents
Other Consumables
Instruments
Software and Services
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Antibody Tests
Viral Load Tests
CD4 Tests
Tests for Early Infant Diagnosis
Tests for Viral Identification
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Abbott
Abbott Healthcare
Abbvie Inc.
Brsitol-Myers Squibb
Janssen Therapeutics
Gilead Sciences
Merck & Co. Inc
VIIV Healthcare
BD Biosciences
Beckman Coulter
Partec
Sysmex
Apogee Flow Systems
PointCare Technologies Inc.
Zyomyx Inc.
Mylan inc.
Roche Diagnostics
Siemens Healthcare
Qiagen
BioMerieux
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global HIV Diagnostics Market Size 2017-2028
2.1.2 HIV Diagnostics Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 HIV Diagnostics Segment by Type
2.2.1 Consumables
2.2.2 Assay, Kits and Reagents
2.2.3 Other Consumables
2.2.4 Instruments
2.2.5 Software and Services
2.3 HIV Diagnostics Market Size by Type
2.3.1 HIV Diagnostics Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global HIV Diagnostics Market Size Market Share by Type (2017-2022)
2.4 HIV Diagnostics Segment by Application
2.4.1 Antibody Tests
2.4.2 Viral Load Tests
2.4.3 CD4 Tests
2.4.4 Tests for Early Infant Diagnosis
2.4.5 Tests for Viral Identification
2.5 HIV Diagnostics Market Size by Application
2.5.1 HIV Diagnostics Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global HIV Diagnostics Market Size Market Share by Application (2017-2022)
3 HIV Diagnostics Market Size by Player
3.1 HIV Diagnostics Market Size Market Share by Players
3.1.1 Global HIV Diagnostics Revenue by Players (2020-2022)
3.1.2 Global HIV Diagnostics Revenue Market Share by Players (2020-2022)
3.2 Global HIV Diagnostics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 HIV Diagnostics by Regions
4.1 HIV Diagnostics Market Size by Regions (2017-2022)
4.2 Americas HIV Diagnostics Market Size Growth (2017-2022)
4.3 APAC HIV Diagnostics Market Size Growth (2017-2022)
4.4 Europe HIV Diagnostics Market Size Growth (2017-2022)
4.5 Middle East & Africa HIV Diagnostics Market Size Growth (2017-2022)
5 Americas
5.1 Americas HIV Diagnostics Market Size by Country (2017-2022)
5.2 Americas HIV Diagnostics Market Size by Type (2017-2022)
5.3 Americas HIV Diagnostics Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC HIV Diagnostics Market Size by Region (2017-2022)
6.2 APAC HIV Diagnostics Market Size by Type (2017-2022)
6.3 APAC HIV Diagnostics Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe HIV Diagnostics by Country (2017-2022)
7.2 Europe HIV Diagnostics Market Size by Type (2017-2022)
7.3 Europe HIV Diagnostics Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa HIV Diagnostics by Region (2017-2022)
8.2 Middle East & Africa HIV Diagnostics Market Size by Type (2017-2022)
8.3 Middle East & Africa HIV Diagnostics Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global HIV Diagnostics Market Forecast
10.1 Global HIV Diagnostics Forecast by Regions (2023-2028)
10.1.1 Global HIV Diagnostics Forecast by Regions (2023-2028)
10.1.2 Americas HIV Diagnostics Forecast
10.1.3 APAC HIV Diagnostics Forecast
10.1.4 Europe HIV Diagnostics Forecast
10.1.5 Middle East & Africa HIV Diagnostics Forecast
10.2 Americas HIV Diagnostics Forecast by Country (2023-2028)
10.2.1 United States HIV Diagnostics Market Forecast
10.2.2 Canada HIV Diagnostics Market Forecast
10.2.3 Mexico HIV Diagnostics Market Forecast
10.2.4 Brazil HIV Diagnostics Market Forecast
10.3 APAC HIV Diagnostics Forecast by Region (2023-2028)
10.3.1 China HIV Diagnostics Market Forecast
10.3.2 Japan HIV Diagnostics Market Forecast
10.3.3 Korea HIV Diagnostics Market Forecast
10.3.4 Southeast Asia HIV Diagnostics Market Forecast
10.3.5 India HIV Diagnostics Market Forecast
10.3.6 Australia HIV Diagnostics Market Forecast
10.4 Europe HIV Diagnostics Forecast by Country (2023-2028)
10.4.1 Germany HIV Diagnostics Market Forecast
10.4.2 France HIV Diagnostics Market Forecast
10.4.3 UK HIV Diagnostics Market Forecast
10.4.4 Italy HIV Diagnostics Market Forecast
10.4.5 Russia HIV Diagnostics Market Forecast
10.5 Middle East & Africa HIV Diagnostics Forecast by Region (2023-2028)
10.5.1 Egypt HIV Diagnostics Market Forecast
10.5.2 South Africa HIV Diagnostics Market Forecast
10.5.3 Israel HIV Diagnostics Market Forecast
10.5.4 Turkey HIV Diagnostics Market Forecast
10.5.5 GCC Countries HIV Diagnostics Market Forecast
10.6 Global HIV Diagnostics Forecast by Type (2023-2028)
10.7 Global HIV Diagnostics Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Abbott
11.1.1 Abbott Company Information
11.1.2 Abbott HIV Diagnostics Product Offered
11.1.3 Abbott HIV Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Abbott Main Business Overview
11.1.5 Abbott Latest Developments
11.2 Abbott Healthcare
11.2.1 Abbott Healthcare Company Information
11.2.2 Abbott Healthcare HIV Diagnostics Product Offered
11.2.3 Abbott Healthcare HIV Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Abbott Healthcare Main Business Overview
11.2.5 Abbott Healthcare Latest Developments
11.3 Abbvie Inc.
11.3.1 Abbvie Inc. Company Information
11.3.2 Abbvie Inc. HIV Diagnostics Product Offered
11.3.3 Abbvie Inc. HIV Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Abbvie Inc. Main Business Overview
11.3.5 Abbvie Inc. Latest Developments
11.4 Brsitol-Myers Squibb
11.4.1 Brsitol-Myers Squibb Company Information
11.4.2 Brsitol-Myers Squibb HIV Diagnostics Product Offered
11.4.3 Brsitol-Myers Squibb HIV Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Brsitol-Myers Squibb Main Business Overview
11.4.5 Brsitol-Myers Squibb Latest Developments
11.5 Janssen Therapeutics
11.5.1 Janssen Therapeutics Company Information
11.5.2 Janssen Therapeutics HIV Diagnostics Product Offered
11.5.3 Janssen Therapeutics HIV Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Janssen Therapeutics Main Business Overview
11.5.5 Janssen Therapeutics Latest Developments
11.6 Gilead Sciences
11.6.1 Gilead Sciences Company Information
11.6.2 Gilead Sciences HIV Diagnostics Product Offered
11.6.3 Gilead Sciences HIV Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Gilead Sciences Main Business Overview
11.6.5 Gilead Sciences Latest Developments
11.7 Merck & Co. Inc
11.7.1 Merck & Co. Inc Company Information
11.7.2 Merck & Co. Inc HIV Diagnostics Product Offered
11.7.3 Merck & Co. Inc HIV Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Merck & Co. Inc Main Business Overview
11.7.5 Merck & Co. Inc Latest Developments
11.8 VIIV Healthcare
11.8.1 VIIV Healthcare Company Information
11.8.2 VIIV Healthcare HIV Diagnostics Product Offered
11.8.3 VIIV Healthcare HIV Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 VIIV Healthcare Main Business Overview
11.8.5 VIIV Healthcare Latest Developments
11.9 BD Biosciences
11.9.1 BD Biosciences Company Information
11.9.2 BD Biosciences HIV Diagnostics Product Offered
11.9.3 BD Biosciences HIV Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 BD Biosciences Main Business Overview
11.9.5 BD Biosciences Latest Developments
11.10 Beckman Coulter
11.10.1 Beckman Coulter Company Information
11.10.2 Beckman Coulter HIV Diagnostics Product Offered
11.10.3 Beckman Coulter HIV Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 Beckman Coulter Main Business Overview
11.10.5 Beckman Coulter Latest Developments
11.11 Partec
11.11.1 Partec Company Information
11.11.2 Partec HIV Diagnostics Product Offered
11.11.3 Partec HIV Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.11.4 Partec Main Business Overview
11.11.5 Partec Latest Developments
11.12 Sysmex
11.12.1 Sysmex Company Information
11.12.2 Sysmex HIV Diagnostics Product Offered
11.12.3 Sysmex HIV Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.12.4 Sysmex Main Business Overview
11.12.5 Sysmex Latest Developments
11.13 Apogee Flow Systems
11.13.1 Apogee Flow Systems Company Information
11.13.2 Apogee Flow Systems HIV Diagnostics Product Offered
11.13.3 Apogee Flow Systems HIV Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.13.4 Apogee Flow Systems Main Business Overview
11.13.5 Apogee Flow Systems Latest Developments
11.14 PointCare Technologies Inc.
11.14.1 PointCare Technologies Inc. Company Information
11.14.2 PointCare Technologies Inc. HIV Diagnostics Product Offered
11.14.3 PointCare Technologies Inc. HIV Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.14.4 PointCare Technologies Inc. Main Business Overview
11.14.5 PointCare Technologies Inc. Latest Developments
11.15 Zyomyx Inc.
11.15.1 Zyomyx Inc. Company Information
11.15.2 Zyomyx Inc. HIV Diagnostics Product Offered
11.15.3 Zyomyx Inc. HIV Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.15.4 Zyomyx Inc. Main Business Overview
11.15.5 Zyomyx Inc. Latest Developments
11.16 Mylan inc.
11.16.1 Mylan inc. Company Information
11.16.2 Mylan inc. HIV Diagnostics Product Offered
11.16.3 Mylan inc. HIV Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.16.4 Mylan inc. Main Business Overview
11.16.5 Mylan inc. Latest Developments
11.17 Roche Diagnostics
11.17.1 Roche Diagnostics Company Information
11.17.2 Roche Diagnostics HIV Diagnostics Product Offered
11.17.3 Roche Diagnostics HIV Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.17.4 Roche Diagnostics Main Business Overview
11.17.5 Roche Diagnostics Latest Developments
11.18 Siemens Healthcare
11.18.1 Siemens Healthcare Company Information
11.18.2 Siemens Healthcare HIV Diagnostics Product Offered
11.18.3 Siemens Healthcare HIV Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.18.4 Siemens Healthcare Main Business Overview
11.18.5 Siemens Healthcare Latest Developments
11.19 Qiagen
11.19.1 Qiagen Company Information
11.19.2 Qiagen HIV Diagnostics Product Offered
11.19.3 Qiagen HIV Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.19.4 Qiagen Main Business Overview
11.19.5 Qiagen Latest Developments
11.20 BioMerieux
11.20.1 BioMerieux Company Information
11.20.2 BioMerieux HIV Diagnostics Product Offered
11.20.3 BioMerieux HIV Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.20.4 BioMerieux Main Business Overview
11.20.5 BioMerieux Latest Developments
12 Research Findings and Conclusion
Table 1. HIV Diagnostics Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Consumables
Table 3. Major Players of Assay, Kits and Reagents
Table 4. Major Players of Other Consumables
Table 5. Major Players of Instruments
Table 6. Major Players of Software and Services
Table 7. HIV Diagnostics Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 8. Global HIV Diagnostics Market Size by Type (2017-2022) & ($ Millions)
Table 9. Global HIV Diagnostics Market Size Market Share by Type (2017-2022)
Table 10. HIV Diagnostics Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 11. Global HIV Diagnostics Market Size by Application (2017-2022) & ($ Millions)
Table 12. Global HIV Diagnostics Market Size Market Share by Application (2017-2022)
Table 13. Global HIV Diagnostics Revenue by Players (2020-2022) & ($ Millions)
Table 14. Global HIV Diagnostics Revenue Market Share by Player (2020-2022)
Table 15. HIV Diagnostics Key Players Head office and Products Offered
Table 16. HIV Diagnostics Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global HIV Diagnostics Market Size by Regions 2017-2022 & ($ Millions)
Table 20. Global HIV Diagnostics Market Size Market Share by Regions (2017-2022)
Table 21. Americas HIV Diagnostics Market Size by Country (2017-2022) & ($ Millions)
Table 22. Americas HIV Diagnostics Market Size Market Share by Country (2017-2022)
Table 23. Americas HIV Diagnostics Market Size by Type (2017-2022) & ($ Millions)
Table 24. Americas HIV Diagnostics Market Size Market Share by Type (2017-2022)
Table 25. Americas HIV Diagnostics Market Size by Application (2017-2022) & ($ Millions)
Table 26. Americas HIV Diagnostics Market Size Market Share by Application (2017-2022)
Table 27. APAC HIV Diagnostics Market Size by Region (2017-2022) & ($ Millions)
Table 28. APAC HIV Diagnostics Market Size Market Share by Region (2017-2022)
Table 29. APAC HIV Diagnostics Market Size by Type (2017-2022) & ($ Millions)
Table 30. APAC HIV Diagnostics Market Size Market Share by Type (2017-2022)
Table 31. APAC HIV Diagnostics Market Size by Application (2017-2022) & ($ Millions)
Table 32. APAC HIV Diagnostics Market Size Market Share by Application (2017-2022)
Table 33. Europe HIV Diagnostics Market Size by Country (2017-2022) & ($ Millions)
Table 34. Europe HIV Diagnostics Market Size Market Share by Country (2017-2022)
Table 35. Europe HIV Diagnostics Market Size by Type (2017-2022) & ($ Millions)
Table 36. Europe HIV Diagnostics Market Size Market Share by Type (2017-2022)
Table 37. Europe HIV Diagnostics Market Size by Application (2017-2022) & ($ Millions)
Table 38. Europe HIV Diagnostics Market Size Market Share by Application (2017-2022)
Table 39. Middle East & Africa HIV Diagnostics Market Size by Region (2017-2022) & ($ Millions)
Table 40. Middle East & Africa HIV Diagnostics Market Size Market Share by Region (2017-2022)
Table 41. Middle East & Africa HIV Diagnostics Market Size by Type (2017-2022) & ($ Millions)
Table 42. Middle East & Africa HIV Diagnostics Market Size Market Share by Type (2017-2022)
Table 43. Middle East & Africa HIV Diagnostics Market Size by Application (2017-2022) & ($ Millions)
Table 44. Middle East & Africa HIV Diagnostics Market Size Market Share by Application (2017-2022)
Table 45. Key Market Drivers & Growth Opportunities of HIV Diagnostics
Table 46. Key Market Challenges & Risks of HIV Diagnostics
Table 47. Key Industry Trends of HIV Diagnostics
Table 48. Global HIV Diagnostics Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 49. Global HIV Diagnostics Market Size Market Share Forecast by Regions (2023-2028)
Table 50. Global HIV Diagnostics Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 51. Global HIV Diagnostics Market Size Market Share Forecast by Type (2023-2028)
Table 52. Global HIV Diagnostics Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 53. Global HIV Diagnostics Market Size Market Share Forecast by Application (2023-2028)
Table 54. Abbott Details, Company Type, HIV Diagnostics Area Served and Its Competitors
Table 55. Abbott HIV Diagnostics Product Offered
Table 56. Abbott HIV Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 57. Abbott Main Business
Table 58. Abbott Latest Developments
Table 59. Abbott Healthcare Details, Company Type, HIV Diagnostics Area Served and Its Competitors
Table 60. Abbott Healthcare HIV Diagnostics Product Offered
Table 61. Abbott Healthcare Main Business
Table 62. Abbott Healthcare HIV Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 63. Abbott Healthcare Latest Developments
Table 64. Abbvie Inc. Details, Company Type, HIV Diagnostics Area Served and Its Competitors
Table 65. Abbvie Inc. HIV Diagnostics Product Offered
Table 66. Abbvie Inc. Main Business
Table 67. Abbvie Inc. HIV Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 68. Abbvie Inc. Latest Developments
Table 69. Brsitol-Myers Squibb Details, Company Type, HIV Diagnostics Area Served and Its Competitors
Table 70. Brsitol-Myers Squibb HIV Diagnostics Product Offered
Table 71. Brsitol-Myers Squibb Main Business
Table 72. Brsitol-Myers Squibb HIV Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 73. Brsitol-Myers Squibb Latest Developments
Table 74. Janssen Therapeutics Details, Company Type, HIV Diagnostics Area Served and Its Competitors
Table 75. Janssen Therapeutics HIV Diagnostics Product Offered
Table 76. Janssen Therapeutics Main Business
Table 77. Janssen Therapeutics HIV Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 78. Janssen Therapeutics Latest Developments
Table 79. Gilead Sciences Details, Company Type, HIV Diagnostics Area Served and Its Competitors
Table 80. Gilead Sciences HIV Diagnostics Product Offered
Table 81. Gilead Sciences Main Business
Table 82. Gilead Sciences HIV Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 83. Gilead Sciences Latest Developments
Table 84. Merck & Co. Inc Details, Company Type, HIV Diagnostics Area Served and Its Competitors
Table 85. Merck & Co. Inc HIV Diagnostics Product Offered
Table 86. Merck & Co. Inc Main Business
Table 87. Merck & Co. Inc HIV Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 88. Merck & Co. Inc Latest Developments
Table 89. VIIV Healthcare Details, Company Type, HIV Diagnostics Area Served and Its Competitors
Table 90. VIIV Healthcare HIV Diagnostics Product Offered
Table 91. VIIV Healthcare Main Business
Table 92. VIIV Healthcare HIV Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 93. VIIV Healthcare Latest Developments
Table 94. BD Biosciences Details, Company Type, HIV Diagnostics Area Served and Its Competitors
Table 95. BD Biosciences HIV Diagnostics Product Offered
Table 96. BD Biosciences Main Business
Table 97. BD Biosciences HIV Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 98. BD Biosciences Latest Developments
Table 99. Beckman Coulter Details, Company Type, HIV Diagnostics Area Served and Its Competitors
Table 100. Beckman Coulter HIV Diagnostics Product Offered
Table 101. Beckman Coulter Main Business
Table 102. Beckman Coulter HIV Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 103. Beckman Coulter Latest Developments
Table 104. Partec Details, Company Type, HIV Diagnostics Area Served and Its Competitors
Table 105. Partec HIV Diagnostics Product Offered
Table 106. Partec HIV Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 107. Partec Main Business
Table 108. Partec Latest Developments
Table 109. Sysmex Details, Company Type, HIV Diagnostics Area Served and Its Competitors
Table 110. Sysmex HIV Diagnostics Product Offered
Table 111. Sysmex Main Business
Table 112. Sysmex HIV Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 113. Sysmex Latest Developments
Table 114. Apogee Flow Systems Details, Company Type, HIV Diagnostics Area Served and Its Competitors
Table 115. Apogee Flow Systems HIV Diagnostics Product Offered
Table 116. Apogee Flow Systems Main Business
Table 117. Apogee Flow Systems HIV Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 118. Apogee Flow Systems Latest Developments
Table 119. PointCare Technologies Inc. Details, Company Type, HIV Diagnostics Area Served and Its Competitors
Table 120. PointCare Technologies Inc. HIV Diagnostics Product Offered
Table 121. PointCare Technologies Inc. Main Business
Table 122. PointCare Technologies Inc. HIV Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 123. PointCare Technologies Inc. Latest Developments
Table 124. Zyomyx Inc. Details, Company Type, HIV Diagnostics Area Served and Its Competitors
Table 125. Zyomyx Inc. HIV Diagnostics Product Offered
Table 126. Zyomyx Inc. Main Business
Table 127. Zyomyx Inc. HIV Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 128. Zyomyx Inc. Latest Developments
Table 129. Mylan inc. Details, Company Type, HIV Diagnostics Area Served and Its Competitors
Table 130. Mylan inc. HIV Diagnostics Product Offered
Table 131. Mylan inc. Main Business
Table 132. Mylan inc. HIV Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 133. Mylan inc. Latest Developments
Table 134. Roche Diagnostics Details, Company Type, HIV Diagnostics Area Served and Its Competitors
Table 135. Roche Diagnostics HIV Diagnostics Product Offered
Table 136. Roche Diagnostics Main Business
Table 137. Roche Diagnostics HIV Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 138. Roche Diagnostics Latest Developments
Table 139. Siemens Healthcare Details, Company Type, HIV Diagnostics Area Served and Its Competitors
Table 140. Siemens Healthcare HIV Diagnostics Product Offered
Table 141. Siemens Healthcare Main Business
Table 142. Siemens Healthcare HIV Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 143. Siemens Healthcare Latest Developments
Table 144. Qiagen Details, Company Type, HIV Diagnostics Area Served and Its Competitors
Table 145. Qiagen HIV Diagnostics Product Offered
Table 146. Qiagen Main Business
Table 147. Qiagen HIV Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 148. Qiagen Latest Developments
Table 149. BioMerieux Details, Company Type, HIV Diagnostics Area Served and Its Competitors
Table 150. BioMerieux HIV Diagnostics Product Offered
Table 151. BioMerieux Main Business
Table 152. BioMerieux HIV Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 153. BioMerieux Latest Developments
List of Figures
Figure 1. HIV Diagnostics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global HIV Diagnostics Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global HIV Diagnostics Market Size Market Share by Type in 2021
Figure 7. HIV Diagnostics in Antibody Tests
Figure 8. Global HIV Diagnostics Market: Antibody Tests (2017-2022) & ($ Millions)
Figure 9. HIV Diagnostics in Viral Load Tests
Figure 10. Global HIV Diagnostics Market: Viral Load Tests (2017-2022) & ($ Millions)
Figure 11. HIV Diagnostics in CD4 Tests
Figure 12. Global HIV Diagnostics Market: CD4 Tests (2017-2022) & ($ Millions)
Figure 13. HIV Diagnostics in Tests for Early Infant Diagnosis
Figure 14. Global HIV Diagnostics Market: Tests for Early Infant Diagnosis (2017-2022) & ($ Millions)
Figure 15. HIV Diagnostics in Tests for Viral Identification
Figure 16. Global HIV Diagnostics Market: Tests for Viral Identification (2017-2022) & ($ Millions)
Figure 17. Global HIV Diagnostics Market Size Market Share by Application in 2021
Figure 18. Global HIV Diagnostics Revenue Market Share by Player in 2021
Figure 19. Global HIV Diagnostics Market Size Market Share by Regions (2017-2022)
Figure 20. Americas HIV Diagnostics Market Size 2017-2022 ($ Millions)
Figure 21. APAC HIV Diagnostics Market Size 2017-2022 ($ Millions)
Figure 22. Europe HIV Diagnostics Market Size 2017-2022 ($ Millions)
Figure 23. Middle East & Africa HIV Diagnostics Market Size 2017-2022 ($ Millions)
Figure 24. Americas HIV Diagnostics Value Market Share by Country in 2021
Figure 25. Americas HIV Diagnostics Consumption Market Share by Type in 2021
Figure 26. Americas HIV Diagnostics Market Size Market Share by Application in 2021
Figure 27. United States HIV Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 28. Canada HIV Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 29. Mexico HIV Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 30. Brazil HIV Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 31. APAC HIV Diagnostics Market Size Market Share by Region in 2021
Figure 32. APAC HIV Diagnostics Market Size Market Share by Application in 2021
Figure 33. China HIV Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 34. Japan HIV Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 35. Korea HIV Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 36. Southeast Asia HIV Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 37. India HIV Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 38. Australia HIV Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 39. Europe HIV Diagnostics Market Size Market Share by Country in 2021
Figure 40. Europe HIV Diagnostics Market Size Market Share by Type in 2021
Figure 41. Europe HIV Diagnostics Market Size Market Share by Application in 2021
Figure 42. Germany HIV Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 43. France HIV Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 44. UK HIV Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 45. Italy HIV Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 46. Russia HIV Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 47. Middle East & Africa HIV Diagnostics Market Size Market Share by Region in 2021
Figure 48. Middle East & Africa HIV Diagnostics Market Size Market Share by Type in 2021
Figure 49. Middle East & Africa HIV Diagnostics Market Size Market Share by Application in 2021
Figure 50. Egypt HIV Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 51. South Africa HIV Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 52. Israel HIV Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 53. Turkey HIV Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 54. GCC Country HIV Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 55. Americas HIV Diagnostics Market Size 2023-2028 ($ Millions)
Figure 56. APAC HIV Diagnostics Market Size 2023-2028 ($ Millions)
Figure 57. Europe HIV Diagnostics Market Size 2023-2028 ($ Millions)
Figure 58. Middle East & Africa HIV Diagnostics Market Size 2023-2028 ($ Millions)
Figure 59. United States HIV Diagnostics Market Size 2023-2028 ($ Millions)
Figure 60. Canada HIV Diagnostics Market Size 2023-2028 ($ Millions)
Figure 61. Mexico HIV Diagnostics Market Size 2023-2028 ($ Millions)
Figure 62. Brazil HIV Diagnostics Market Size 2023-2028 ($ Millions)
Figure 63. China HIV Diagnostics Market Size 2023-2028 ($ Millions)
Figure 64. Japan HIV Diagnostics Market Size 2023-2028 ($ Millions)
Figure 65. Korea HIV Diagnostics Market Size 2023-2028 ($ Millions)
Figure 66. Southeast Asia HIV Diagnostics Market Size 2023-2028 ($ Millions)
Figure 67. India HIV Diagnostics Market Size 2023-2028 ($ Millions)
Figure 68. Australia HIV Diagnostics Market Size 2023-2028 ($ Millions)
Figure 69. Germany HIV Diagnostics Market Size 2023-2028 ($ Millions)
Figure 70. France HIV Diagnostics Market Size 2023-2028 ($ Millions)
Figure 71. UK HIV Diagnostics Market Size 2023-2028 ($ Millions)
Figure 72. Italy HIV Diagnostics Market Size 2023-2028 ($ Millions)
Figure 73. Russia HIV Diagnostics Market Size 2023-2028 ($ Millions)
Figure 74. Spain HIV Diagnostics Market Size 2023-2028 ($ Millions)
Figure 75. Egypt HIV Diagnostics Market Size 2023-2028 ($ Millions)
Figure 76. South Africa HIV Diagnostics Market Size 2023-2028 ($ Millions)
Figure 77. Israel HIV Diagnostics Market Size 2023-2028 ($ Millions)
Figure 78. Turkey HIV Diagnostics Market Size 2023-2028 ($ Millions)
Figure 79. GCC Countries HIV Diagnostics Market Size 2023-2028 ($ Millions)
This report provides an overview of the French molecular diagnostic testing market, including test volume, and sales forecasts by Application, 2019-2023, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
This report provides an overview of the German molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
This report provides an overview of the Italian molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...